Systemic administration of a TLR7 agonist attenuates regulatory T cells by dendritic cell modification and overcomes resistance to PD-L1 blockade therapy. (Q51736282)
Jump to navigation
Jump to search
scientific article published on 27 January 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Systemic administration of a TLR7 agonist attenuates regulatory T cells by dendritic cell modification and overcomes resistance to PD-L1 blockade therapy. |
scientific article published on 27 January 2018 |
Statements
1 reference
Systemic administration of a TLR7 agonist attenuates regulatory T cells by dendritic cell modification and overcomes resistance to PD-L1 blockade therapy. (English)
1 reference
Naoto Nishii
1 reference
Hidetake Tachinami
1 reference
Yuta Kondo
1 reference
Yulong Xia
1 reference
Yoshihisa Kashima
1 reference
Tatsukuni Ohno
1 reference
Shigenori Nagai
1 reference
Lixin Li
1 reference
Walter Lau
1 reference
Hiroyuki Harada
1 reference
Miyuki Azuma
1 reference
27 January 2018
1 reference
1 reference
9
1 reference
17
1 reference
13301-13312
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference